Meeder Asset Management’s Phibro Animal Health PAHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $109K | Sell |
1,969
-6,211
| -76% | -$296K | 0.01% | 351 |
|
|
2025
Q4 | $306K | Hold |
8,180
| – | – | 0.02% | 240 |
|
|
2025
Q3 | $331K | Hold |
8,180
| – | – | 0.02% | 190 |
|
|
2025
Q2 | $209K | Buy |
8,180
+2,806
| +52% | +$61.2K | 0.01% | 242 |
|
|
2025
Q1 | $115K | Hold |
5,374
| – | – | 0.01% | 301 |
|
|
2024
Q4 | $113K | Buy |
+5,374
| New | +$124K | 0.01% | 275 |
|
|
2022
Q4 | – | Sell |
-57
| Closed | -$1K | – | 1629 |
|
|
2022
Q3 | $1K | Sell |
57
-5
| -8% | -$86 | ﹤0.01% | 1990 |
|
|
2022
Q2 | $1K | Hold |
62
| – | – | ﹤0.01% | 2045 |
|
|
2022
Q1 | $1K | Buy |
62
+21
| +51% | +$424 | ﹤0.01% | 2224 |
|
|
2021
Q4 | $1K | Buy |
41
+5
| +14% | +$107 | ﹤0.01% | 1036 |
|
|
2021
Q3 | $1K | Buy |
36
+4
| +13% | +$96 | ﹤0.01% | 2353 |
|
|
2021
Q2 | $1K | Hold |
32
| – | – | ﹤0.01% | 2372 |
|
|
2021
Q1 | $1K | Buy |
32
+11
| +52% | +$248 | ﹤0.01% | 2239 |
|
|
2020
Q4 | $0 | Sell |
21
-4,354
| -100% | -$80.1K | ﹤0.01% | 2123 |
|
|
2020
Q3 | $76K | Sell |
4,375
-5,087
| -54% | -$109K | ﹤0.01% | 860 |
|
|
2020
Q2 | $249K | Sell |
9,462
-22
| -0.2% | -$546 | 0.02% | 546 |
|
|
2020
Q1 | $230K | Sell |
9,484
-2,664
| -22% | -$65.1K | 0.02% | 534 |
|
|
2019
Q4 | $301K | Sell |
12,148
-1,572
| -11% | -$36.5K | 0.02% | 497 |
|
|
2019
Q3 | $293K | Buy |
13,720
+2,978
| +28% | +$81.6K | 0.02% | 514 |
|
|
2019
Q2 | $341K | Buy |
10,742
+1,142
| +12% | +$35.8K | 0.02% | 468 |
|
|
2019
Q1 | $317K | Buy |
9,600
+3,710
| +63% | +$115K | 0.03% | 458 |
|
|
2018
Q4 | $189K | Sell |
5,890
-138
| -2% | -$5.21K | 0.02% | 510 |
|
|
2018
Q3 | $258K | Buy |
6,028
+1,558
| +35% | +$73.6K | 0.02% | 464 |
|
|
2018
Q2 | $206K | Buy |
4,470
+2,676
| +149% | +$118K | 0.02% | 507 |
|
|
2018
Q1 | $72K | Buy |
1,794
+373
| +26% | +$13.8K | 0.01% | 604 |
|
|
2017
Q4 | $48K | Buy |
1,421
+344
| +32% | +$12.2K | ﹤0.01% | 705 |
|
|
2017
Q3 | $40K | Buy |
1,077
+951
| +755% | +$35.7K | ﹤0.01% | 727 |
|
|
2017
Q2 | $5K | Sell |
126
-139
| -52% | -$4.54K | ﹤0.01% | 1199 |
|
|
2017
Q1 | $7K | Buy |
+265
| New | +$7.48K | ﹤0.01% | 959 |
|
|
2016
Q3 | – | Sell |
-7,888
| Closed | -$147K | – | 898 |
|
|
2016
Q2 | $147K | Sell |
7,888
-5,561
| -41% | -$116K | 0.01% | 612 |
|
|
2016
Q1 | $364K | Hold |
13,449
| – | – | 0.03% | 479 |
|
|
2015
Q4 | $405K | Hold |
13,449
| – | – | 0.04% | 406 |
|
|
2015
Q3 | $425K | Buy |
+13,449
| New | +$491K | 0.04% | 417 |
|
Other funds holding PAHC
VCM
VPM
N
Meeder Asset Management's PAHC Position: Q1 2026 in Review
Meeder Asset Management reduced its Phibro Animal Health (PAHC) stake by 76% in Q1 2026, selling an estimated $296K and leaving 1,969 shares worth $109K. The position accounts for 0.01% of the portfolio, ranked #351.
Meeder Asset Management first reported a position in PAHC in Q3 2015 and has held it in 33 quarters since. The position peaked at $425K in Q3 2015. 257 funds tracked by Wall St. Rank hold PAHC as of Q1 2026.
- Meeder Asset Management held 1,969 shares of Phibro Animal Health worth $109K as of Q1 2026.
- Meeder Asset Management sold 6,211 Phibro Animal Health shares in Q1 2026, an estimated $296K.
- Phibro Animal Health made up 0.01% of Meeder Asset Management's portfolio in Q1 2026, its #351 holding.
- Meeder Asset Management first reported a position in Phibro Animal Health in Q3 2015 and has held it in 33 quarters since.
- Meeder Asset Management's Phibro Animal Health position peaked at $425K in Q3 2015.
- 257 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2026.
Based on Meeder Asset Management's 13F filing for Q1 2026, filed 7 May 2026.